Ranbaxy Laboratories Ltd said it was planning to achieve $3 billion in consolidated turnover by 2012 as part of its medium-term business plan. Ranbaxy, majority owned by Japan's Daiichi Sankyo, did not give details in the notice to the Bombay Stock Exchange.

India's largest pharmaceutical company, Ranbaxy is an integrated, research based, pharmaceutical company that produces a wide range of generic medicines. The company has manufacturing facilities in 7 countries and serves customers in over 125 countries.

In June 2008, Ranbaxy entered into an alliance with one of the largest Japanese innovator companies, Daiichi Sankyo Company Ltd. The combined entity now ranks among the top 20 pharmaceutical companies, globally.